Model
Edge
Five Prime Therapeutics, Inc.
0001518724
Filing Type
4
Filing Date
5/17/2020
Updated
5/18/20, 4:36 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership